Oxford Nanopore Technologies Ltd - Asset Resilience Ratio

Latest as of December 2025: 11.92%

Oxford Nanopore Technologies Ltd (ONT) has an Asset Resilience Ratio of 11.92% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

GBX74.20 Million

≈ $9.03K USD Cash + Short-term Investments

Total Assets

GBX622.50 Million

≈ $75.74K USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2012–2025)

This chart shows how Oxford Nanopore Technologies Ltd's Asset Resilience Ratio has changed over time. Check ONT strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Oxford Nanopore Technologies Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Oxford Nanopore Technologies Ltd (ONT) market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	GBX0.00	0%
Short-term Investments	GBX74.20 Million	11.92%
Total Liquid Assets	GBX74.20 Million	11.92%

Asset Resilience Insights

Moderate Liquidity: Oxford Nanopore Technologies Ltd has 11.92% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Oxford Nanopore Technologies Ltd Industry Peers by Asset Resilience Ratio

Compare Oxford Nanopore Technologies Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
argenx NV ADR NASDAQ:ARGX	Biotechnology	10.93%
Shanghai Allist Pharmaceuticals Co. Ltd. A SHG:688578	Biotechnology	21.11%
Tubize-Fin BR:TUB	Biotechnology	0.05%
Tango Therapeutics Inc NASDAQ:TNGX	Biotechnology	57.90%
TELIX Pharmaceuticals Ltd AU:TLX	Biotechnology	32.29%
Inner Mongolia Furui Med Sci SHE:300049	Biotechnology	2.34%
Bicara Therapeutics Inc. Common Stock NASDAQ:BCAX	Biotechnology	39.07%
Damora Therapeutics, Inc. NASDAQ:DMRA	Biotechnology	0.00%

Annual Asset Resilience Ratio for Oxford Nanopore Technologies Ltd (2012–2025)

The table below shows the annual Asset Resilience Ratio data for Oxford Nanopore Technologies Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	11.92%	GBX74.20 Million ≈ $9.03K	GBX622.50 Million ≈ $75.74K	-6.79pp
2024-12-31	18.71%	GBX138.85 Million ≈ $16.89K	GBX742.05 Million ≈ $90.29K	+12.34pp
2023-12-31	6.37%	GBX49.51 Million ≈ $6.02K	GBX777.06 Million ≈ $94.55K	-8.12pp
2022-12-31	14.49%	GBX119.41 Million ≈ $14.53K	GBX823.89 Million ≈ $100.24K	-1.02pp
2021-12-31	15.52%	GBX130.63 Million ≈ $15.89K	GBX841.87 Million ≈ $102.43K	-17.59pp
2018-12-31	33.11%	GBX58.00 Million ≈ $7.06K	GBX175.19 Million ≈ $21.32K	+24.73pp
2017-12-31	8.38%	GBX10.00 Million ≈ $1.22K	GBX119.31 Million ≈ $14.52K	-29.37pp
2016-12-31	37.75%	GBX60.00 Million ≈ $7.30K	GBX158.94 Million ≈ $19.34K	-3.67pp
2015-12-31	41.42%	GBX45.06 Million ≈ $5.48K	GBX108.77 Million ≈ $13.23K	-9.96pp
2014-12-31	51.38%	GBX36.12 Million ≈ $4.39K	GBX70.30 Million ≈ $8.55K	+3.24pp
2013-12-31	48.14%	GBX33.15 Million ≈ $4.03K	GBX68.87 Million ≈ $8.38K	+3.77pp
2012-12-31	44.37%	GBX23.05 Million ≈ $2.80K	GBX51.95 Million ≈ $6.32K	--

pp = percentage points

About Oxford Nanopore Technologies Ltd

LSE:ONT UK Biotechnology

Market Cap

$13.84 Million

GBX113.78 Billion GBX

Market Cap Rank

#26201 Global

#305 in UK

Share Price

GBX117.00

Change (1 day)

+0.26%

52-Week Range

GBX104.50 - GBX219.00

All Time High

GBX716.00